MYELIN BASIC PROTEIN-LIKE MATERIAL--DELAYED MYELOGENESIS MONITOR
MYELIN BASIC PROTEIN-LIKE MATERIAL--DELAYED MYELOGENESIS MONITOR
批准号:
6241299
负责人:
JOHN N WHITAKER
金额:
$12.83万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-01 至 1998-07-31
关键词:
biomarker developmental neurobiology developmental nutrition disease /disorder proneness /risk high performance liquid chromatography human subject infant human (0-1 year) longitudinal human study low birth weight infant human myelin basic proteins myelination myelinopathy nervous system disorder diagnosis noninvasive diagnosis nutrition related tag patient /disease registry preschool child (1-5) radioimmunoassay urinalysis
中文摘要
这一建议建立在这样的假设之上,即尿肽水平
与髓鞘碱性蛋白(MBP)相关的免疫反应
髓鞘生成,可以提供成功或失败的监测
儿童的髓鞘生成。不确定的进程,亚临床
受累程度和临床和生物异质性
MR/DD患者群体试图进行治疗或
基于临床评价的介入试验难度大、难度大
持续时间长,而且往往没有定论。在某种程度上,这个问题代表着
不能充分评估损伤或失败的神经发育
准确地说。这一提议代表了一种潜在的强有力的手段
以非侵入性方式解决这一问题并推动
诊断和预后能力以及监测有效性
干预策略。
这项研究的具体目的是:(A)记录规范性文件
从MBPLM的存在看髓鞘形成的发育过程
从出生到4岁的尿液(研究1);(B)
极低出生体重(VLBW),小于1000克,高危样本
对于脑室周围白质软化(PVL)和髓鞘生成异常,
出生时至4岁期间是否存在MBPLM(研究2);(C)至
对极低出生体重儿从出生到4岁进行纵向研究
确定个人成长曲线和测试性别的年龄
MBPLM随时间的差异(研究3);(D)与MBPLM水平相关
及其随时间的变化对MR/DD临床表现的影响
极低出生体重儿的横断面和纵向样本;
用高效液相色谱(HPLC)表征
出生后4岁以下儿童MBPLM的特征;(F)寻找
存在由外显子2或MBP编码的MBPLM,仅在
髓鞘生成;(G)寻找物质是否存在交叉反应
与MBP的瓜氨酸(C8)异构体,在第一电荷中
在髓鞘形成过程中出现的异构体;和(H)获得档案
儿童MBPLM水平的临床数据库(研究4)
与发育障碍相关的相对罕见的发育障碍
髓鞘生成,如甲状腺功能减退症、白质营养不良、有机酸
紊乱,和氨基酸紊乱(包括PKU)。
我们认识到,拟议的研究在以下方面是探索性的
产生有意义的信息。然而,可靠的非侵入性标记
目前还缺乏髓鞘形成的相关基因。这种最新的方法论
突破性进展提供了独特的关联机会
正常人群的神经发育特征和描述
具有髓鞘生成标记的队列。因此,这些研究已经
提高对正常的理解的知识的巨大潜力
和异常的发育。
英文摘要
This proposal rests on the hypothesis that the level of a urinary peptide
which is immunoreactive with myelin basic protein (MBP) correlates with
myelinogenesis and can provide a monitor of successful or failed
myelinogenesis in children. The uncertain course, subclinical
involvement and clinical and biological heterogeneity within the
population of MR/DD patients render attempts at therapeutic or
interventional trials based on clinical evaluation difficult, of long
duration, and often inconclusive. To some extent, the problem represents
an inability to assess injury or failed neurodevelopment adequately and
accurately. This proposal represents a potentially powerful means of
addressing this issue in a noninvasive manner and the advancing
diagnostic and prognostic capabilities and monitoring the effectiveness
of intervention strategies.
The specific aims of this study are: (A) to document the normative
developmental course of myelinogenesis in terms of the presence of MBPLM
in urine from birth through 4 years of age (Study 1); (B) to determine
in a very low birthweight (VLBW), less than 1000 gm, sample at high risk
for peri-ventricular leukomalacia (PVL) and abnormal myelinogenesis, the
presence of MBPLM at birth through 4 years of age (Study 2); (C) to
conduct a longitudinal study of VLBW children from birth to 4 years of
age to ascertain individual growth curves and to test for gender
differences in MBPLM over time (Study 3); (D) to relate levels of MBPLM
and their changes over time to clinical manifestations of MR/DD in the
cross-sectional and longitudinal samples of VLBW children; (E) to
characterize by high performance liquid chromatography (HPLC) the
features of MBPLM at birth through 4 years; (F) to search for the
presence of MBPLM encoded by exon 2 or MBP, expressed only during
myelinogenesis; (G) to search for the presence of material cross-reactive
with the citrullinated (C8) isomer of MBP, among the first charged
isomers to appear during myelinogenesis; and (H) to acquire an archival
clinical database on MBPLM levels in children (Study 4) with specific,
relatively rare developmental disabilities associated with disorders of
myelinogenesis, e.g. hypothyroidism, leukodystrophies, organic acid
disorders, and amino acid disorders (including PKU).
We recognize that the proposed studies are exploratory in terms of
yielding meaningful information. However, reliable non-invasive markers
of myelinogenesis re presently lacking. This recent methodologic
breakthrough provides a unique opportunity to correlate
neurodevelopmental characteristics in well-established and delineated
cohorts with a marker of myelinogenesis. Thus, these studies have
substantial potential for advancing knowledge about understanding normal
and aberrant development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IDIOTYPES AND INFLAMMATORY DEMYELINATION
-
批准号:6302803
-
项目类别:
-
资助金额:$22.61万
-
财政年份:2000
-
负责人:JOHN N WHITAKER
-
依托单位:
IDIOTYPES AND INFLAMMATORY DEMYELINATION
-
批准号:6112375
-
项目类别:
-
资助金额:$22.61万
-
财政年份:1999
-
负责人:JOHN N WHITAKER
-
依托单位:
MYELIN BASIC PROTEIN-LIKE MATERIAL--DELAYED MYELOGENESIS MONITOR
-
批准号:6108776
-
项目类别:
-
资助金额:$13.89万
-
财政年份:1998
-
负责人:JOHN N WHITAKER
-
依托单位:
IDIOTYPES AND INFLAMMATORY DEMYELINATION
-
批准号:6273790
-
项目类别:
-
资助金额:$22.47万
-
财政年份:1998
-
负责人:JOHN N WHITAKER
-
依托单位:
IDIOTYPES AND INFLAMMATORY DEMYELINATION
-
批准号:6243689
-
项目类别:
-
资助金额:$22.6万
-
财政年份:1997
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR IMMUNOPATHOGENESIS OF DEMYELINATING DISEASE
-
批准号:2685680
-
项目类别:
-
资助金额:$89.87万
-
财政年份:1991
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR IMMUNOPATHOGENESIS OF DEMYELINATING DISEASE
-
批准号:3100371
-
项目类别:
-
资助金额:$72.67万
-
财政年份:1991
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR IMMUNOPATHOGENESIS OF DEMYELINATING DISEASE
-
批准号:3100369
-
项目类别:
-
资助金额:$2.99万
-
财政年份:1991
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR IMMUNOPATHOGENESIS OF DEMYELINATING DISEASE
-
批准号:3100368
-
项目类别:
-
资助金额:$64.45万
-
财政年份:1991
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR IMMUNOPATHOGENESIS OF DEMYELINATING DISEASE
-
批准号:2267846
-
项目类别:
-
资助金额:$79.32万
-
财政年份:1991
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR IMMUNOPATHOGENESIS OF DEMYELINATING DISEASE
-
批准号:2267847
-
项目类别:
-
资助金额:$82.95万
-
财政年份:1991
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR IMMUNOPATHOGENESIS OF DEMYELINATING DISEASE
-
批准号:2267848
-
项目类别:
-
资助金额:$88.54万
-
财政年份:1991
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR IMMUNOPATHOGENESIS OF DEMYELINATING DISEASE
-
批准号:3100370
-
项目类别:
-
资助金额:$69.88万
-
财政年份:1991
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR IMMUNOPATHOGENESIS OF DEMYELINATING DISEASE
-
批准号:2393110
-
项目类别:
-
资助金额:$90.4万
-
财政年份:1991
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR IMMUNOPATHOGENESIS OF DEMYELINATING DISEASE
-
批准号:2891804
-
项目类别:
-
资助金额:$90.45万
-
财政年份:1991
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR NEUROIMMUNOLOGY AND NEUROIMMUNODULATION
-
批准号:2260541
-
项目类别:
-
资助金额:$12.83万
-
财政年份:1990
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR NEUROIMMUNOLOGY AND NEUROIMMUNODULATION
-
批准号:3544209
-
项目类别:
-
资助金额:$14.12万
-
财政年份:1990
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR NEUROIMMUNOLOGY AND NEUROIMMUNODULATION
-
批准号:3544208
-
项目类别:
-
资助金额:$12.52万
-
财政年份:1990
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR NEUROIMMUNOLOGY AND NEUROIMMUNODULATION
-
批准号:3544207
-
项目类别:
-
资助金额:$9.13万
-
财政年份:1990
-
负责人:JOHN N WHITAKER
-
依托单位:
MOLECULAR NEUROIMMUNOLOGY AND NEUROIMMUNODULATION
-
批准号:2260540
-
项目类别:
-
资助金额:$12.06万
-
财政年份:1990
-
负责人:JOHN N WHITAKER
-
依托单位:
海外基金